DKBmed Podcasts – Medical Education Podcasts
Volume 6, Issue 6
In this podcast follow-up to their recent eViralHepatitis Review newsletter issue (Vol. 6, No. 5), Dr. Mandana Khalili and Dr. Michele Tana from the University of California, San Francisco discuss how their analysis of the newer published information can impact clinical practice.
Take our post-test to claim CME credits.
To read a companion newsletter click here
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 6, Issue 4.
People who inject drugs (PWID) comprise a rapidly growing population of HCV-infected people who have historically been difficult to reach and treat. But without engagement in HCV care, PWID will continue to transmit the virus and impede efforts for hepatitis C eradication.
In this issue, Dr. Arthur Kim from Massachusetts General Hospital and Harvard Medical School provides a clinical perspective on identifying and overcoming the barriers that prevent PWID from effectively receiving HCV treatment.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 6, Issue 2.
In this podcast Andrea Granados, MD describes the clinical impact of the early diagnosis of glucose abnormalities in people with CF, summarizes the limitations of alternative modalities for screening and diagnosing CFRD, and and identifies the current recommendations for the management of CFRD.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Counseling about hepatitis C transmission and alcohol consumption and treatment with medications that are simpler, faster and more effective than ever. All possible in primary care. Take the post-test to claim your credit.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Learn the basics of hepatitis C, including how the virus is transmitted, who to screen for the infection, and why screening is critical to interrupting the epidemic of hepatitis C and its life-threatening consequences. Take the post-test to claim your credit.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Hep C (HCV) treatment is easier and more effective, than ever. Cure is almost always expected when treated—even current drug users—so learn how you can cure HCV and help prevent re-infection, liver damage, cancer and death. Take the post-test to claim your credit.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Hepatitis C is a huge killer, but it doesn’t have to be. Cure is possible, even among drug users. Be part of the cure by learning what is involved in screening (hint: not much) and how screening can save lives. Take the post-test to claim your credit.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 5, Issue 12.
In this podcast Dr. Ira Jacobson discusses New Options for Patients with “Hard-To-Treat” Hepatitis C Infection.
Take our post-test to claim CME credits:
Physician post-test
Nurse post-test
To read a companion newsletter click here.
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 5, Issue 10.
In this podcast Dr. David Wyles discusses managing DAA failures with the newly approved treatment options for hepatitis C.
Take our post-test to claim CME credits:
Physician post-test
Nurse post-test
To read a companion newsletter click here.
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 5, Issue 8.
In this podcast, Andrew J. Muir, MD from Duke University School of Medicine discusses the real-world data to support a sofosbuvir-ledipasvir treatment duration of 8 weeks versus 12 weeks, summarizes the current hepatitis C treatment options for patients with advanced kidney disease, and describes the risks and benefits of hepatitis C therapies in HIV-HCV coinfected patients.
Take our post-test to claim CME credits:
Physician post-test
Nurse post-test
To read a companion newsletter click here.
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS